ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression

NCT07327034 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: ABSK-011+BSC
DRUG: Placebo+BSC

Sponsor

Abbisko Therapeutics Co, Ltd